1981 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuliano Torre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

AISF position paper on HCV in immunocompromised patients

(AISF), I. A. F. T. S. O. T. L., Marzano, A., Angelucci, E., Astegiano, M., Baratelli, C., Biancone, L., Bironzo, P., Brancaccio, G., Brunetto, M. R., Bruno, R., Burra, P., Cabras, M. G., Caraceni, P., Chialà, C., Clemente, M. G., Colli, A., Daniele, B., De Gasperi, E., Di Marco, V., Ditto, M. C. & 31 others, Fagiuoli, S., Ferri, C., Gaeta, G. B., Grossi, P. A., Imperatrice, B., Lampertico, P., Macaluso, F. S., Madonia, S., Marignani, M., Mazzarelli, C., Mella, A., Missale, G., Parisi, S., Pasulo, L., Puoti, M., Rendina, M., Ribaldone, D., Rossi, G., Toniutto, P., Tucci, A., Vajro, P., Viganò, M., Volpes, R., Zignego, A. L., Giannini, E. G., Miele, L., Russo, F. P., Petta, S., Di Maio, M., Rizzetto, M. & Torre, G., Jan 1 2019, In : Dig. Liver Dis.. 51, 1, p. 10-23 14 p.

Research output: Contribution to journalArticle

  • AISF position paper on HCV in immunocompromised patients

    Italian Association for the Study of the Liver (AISF), Jan 1 2019, In : Digestive and Liver Disease. 51, 1, p. 10-23 14 p.

    Research output: Contribution to journalArticle

  • AISF position paper on HCV in immunocompromised patients: Digestive and Liver Disease

    Italian Association for the Study of the Liver (AISF), 2019, In : Dig. Liver Dis.. 51, 1, p. 10-23 14 p.

    Research output: Contribution to journalArticle

    Infections and malignancies risks related to TNF-α-blocking agents in pediatric inflammatory bowel diseases

    Alvisi, P., Dipasquale, V., Barabino, A., Martellossi, S., Miele, E., Lionetti, P., Lombardi, G., Cucchiara, S., Torre, G. & Romano, C., Sep 6 2019, In : Expert Review of Gastroenterology and Hepatology. p. 1-5 5 p.

    Research output: Contribution to journalArticle

  • Phase I/II Trial of Liver Derived Mesenchymal Stem Cells in Pediatric Liver Based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-Derived Progenitor Cells (HepaStem®) in Urea Cycle Disorders and Crigler-Najjar Syndrome patients

    Smets, F., Dobbelaere, D., McKiernan, P., Dionisi-Vici, C., Broué, P., Jacquemin, E., Lopes, A. I., Gonçalves, I., Mandel, H., Pawlowska, J., Kamińska, D., Shteyer, E., Torre, G., Shapiro, R., Eyskens, F., Clapuyt, P., Gissen, P., Pariente, D., Grunewald, S., Yudkoff, M. & 6 others, Binda, M. M., Najimi, M., Belmonte, N., Vos, B. D., Thonnard, J. & Sokal, E., Feb 18 2019, In : Transplantation.

    Research output: Contribution to journalArticle